ESPOSITO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.864
EU - Europa 8.564
AS - Asia 7.576
SA - Sud America 852
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 16
Totale 32.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.637
GB - Regno Unito 2.749
CN - Cina 2.285
SG - Singapore 2.243
IT - Italia 2.206
SE - Svezia 1.020
HK - Hong Kong 922
VN - Vietnam 734
BR - Brasile 658
DE - Germania 594
UA - Ucraina 443
FI - Finlandia 419
TR - Turchia 409
FR - Francia 291
RU - Federazione Russa 270
KR - Corea 263
IN - India 201
BG - Bulgaria 145
CA - Canada 111
NL - Olanda 101
AR - Argentina 76
MX - Messico 73
BD - Bangladesh 72
ZA - Sudafrica 58
IQ - Iraq 55
LT - Lituania 53
ID - Indonesia 49
PL - Polonia 45
IE - Irlanda 40
PK - Pakistan 40
JP - Giappone 38
IR - Iran 37
AE - Emirati Arabi Uniti 31
ES - Italia 31
BE - Belgio 29
CO - Colombia 28
PH - Filippine 26
EU - Europa 24
IL - Israele 23
EC - Ecuador 22
UZ - Uzbekistan 21
CL - Cile 20
AT - Austria 17
EG - Egitto 17
MY - Malesia 17
JO - Giordania 16
PE - Perù 16
SA - Arabia Saudita 16
CH - Svizzera 15
MA - Marocco 15
VE - Venezuela 14
AU - Australia 13
DZ - Algeria 12
KE - Kenya 12
TH - Thailandia 12
RO - Romania 10
RS - Serbia 10
GR - Grecia 9
KZ - Kazakistan 9
PY - Paraguay 9
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
PA - Panama 8
DK - Danimarca 7
PT - Portogallo 7
AZ - Azerbaigian 6
CR - Costa Rica 6
JM - Giamaica 6
NO - Norvegia 6
SI - Slovenia 6
TN - Tunisia 6
AL - Albania 5
ET - Etiopia 5
GE - Georgia 5
HN - Honduras 5
KW - Kuwait 5
LV - Lettonia 5
TW - Taiwan 5
UY - Uruguay 5
AM - Armenia 4
EE - Estonia 4
LB - Libano 4
MD - Moldavia 4
NP - Nepal 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
MG - Madagascar 3
NZ - Nuova Zelanda 3
OM - Oman 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
CU - Cuba 2
HU - Ungheria 2
NG - Nigeria 2
Totale 32.016
Salva come PNG Salva come JPEG
Città #
Southend 2.066
Santa Clara 1.555
Singapore 1.475
Ashburn 1.179
Fairfield 1.105
Woodbridge 1.011
Chandler 918
Hong Kong 895
Jacksonville 796
Hefei 787
Houston 673
Dearborn 572
Nyköping 514
Wilmington 493
Beijing 479
Ann Arbor 449
Seattle 383
Cambridge 374
San Jose 350
London 340
Los Angeles 305
Chicago 289
Helsinki 263
Seoul 249
Izmir 245
Ho Chi Minh City 213
The Dalles 194
Milan 178
New York 171
Rome 170
Hanoi 167
Princeton 147
Sofia 138
Eugene 135
Council Bluffs 127
Dallas 121
Salt Lake City 118
San Diego 118
Modena 116
Buffalo 115
Lauterbourg 111
Des Moines 105
Shanghai 95
Frankfurt am Main 88
Moscow 80
Naples 78
São Paulo 68
Tampa 63
Munich 58
Elk Grove Village 52
Orem 48
Da Nang 46
Bologna 44
Philadelphia 42
Columbus 40
Palermo 38
Nanjing 37
Warsaw 36
Florence 35
Montreal 35
Bari 34
Bremen 34
Guangzhou 34
Haiphong 33
Dublin 32
Boardman 31
Chennai 31
Redwood City 29
Tokyo 29
Toronto 29
Kent 28
Sterling 28
Verona 27
Turin 26
Johannesburg 25
Mexico City 25
Mumbai 24
Brescia 23
Brooklyn 23
Brussels 23
Kunming 23
Amsterdam 22
Augusta 22
Jakarta 22
San Mateo 22
Atlanta 21
Baghdad 21
Catania 21
Falkenstein 21
Norwalk 21
Ottawa 20
Boston 19
Detroit 19
Lancaster 19
Miami 19
Parma 19
Rio de Janeiro 19
Tashkent 19
Phoenix 18
Turku 18
Totale 22.165
Salva come PNG Salva come JPEG
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.711
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 491
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 407
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease. 382
Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients 380
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 379
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study 358
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 355
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 352
Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients 337
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 334
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 325
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 321
Efficacy and safety of atazanavir in patients with end-stage liver disease. 316
La clinica metabolica per il trattamento della lipodistrofia 316
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 315
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 307
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 297
Gli ascessi epatici nei pazienti sottoposi a trapianto ortotopico di fegato 297
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 296
Outcome, incidence, and timing of infections in small bowel/multivisceral transplantation 295
Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. 291
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 289
Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV-Protease Inhibitors Postliver Transplant. 288
Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. 287
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 286
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 285
Fatal cytomegalovirus necrotising enteritis in a small bowel transplantation adult recipient with low pp65 antigenaemia levels 282
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 281
Brucellosis in a patient with end-stage liver disease undergoing liver transplantation: successful treatment with tigecycline. 280
Detectable HIV viral load is associated with metabolic syndrome 277
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection 276
Applicazione della scala di valutazione, Functional indipendence Measure (FIM), per la valutazione dei programmi di riabilitazione per pazienti affetti da AIDS Dementia Complex ospiti di una casa alloggio 274
Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function. 274
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 273
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 270
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: An international observational study 270
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 265
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 264
Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy 263
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 261
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 260
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 260
Raltegravir and enfuvirtide as a “bridge” antiretroviral therapy in kidney-tranplanted patients with HIV infection receiving everolimus and low-dose cyclosporine: a case-control study 259
Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation 258
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 255
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 252
Immunophenotype of HIV plus patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system 250
Age-related comorbidities in people living with HIV 249
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 249
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 248
Artropodi vettori di agenti infettivi 245
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 239
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 237
Improving the appropriateness of antibiotic prescription in hospitals: a pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme 237
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 237
Un caso di tubercolosi post-trapianto ortotopico di fegato: limiti dell’impiego del quantiferon-TB gold nella diagnosi della infezione tubercolare latente ed attiva 237
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 235
Bloodstream infections (BSIs) in Liver Transplant Recipients: Analisys at an Italian Tertiary-Care Hospital 232
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 231
Severity of lipodystrophy is associated with decreased health-related quality of life 230
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 229
Prevalence of secondary causes of osteoporosis among HIV infected individuals 228
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 10(6) cells/I 227
Does lipodistrophy affect quality of life? 222
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 220
Body Image perception in HIV infected women with body fat redistribution. 216
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease 214
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 214
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 211
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 210
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 205
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 205
Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of quantiferon TB GOLD results in the transplant setting: A case report 204
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 203
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 203
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 201
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 199
Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: Report of three cases 199
Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation 199
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 193
È possibile un counselling HIV su internet? 193
GH response to GH-releasing hormone-arginine (GHRH+Arg) is impaired in women affected by human immunodeficiency virus (HIV)-related lipodystrophy 193
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: The CARe study 192
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 192
La trasmissione verticale di HIV nell’era della HAART 191
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study 191
Body fat redistribution syndrome in HIV infected people is associated with good adherence to HAART 189
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 188
CD4-Guided treatment interruptions: a new possibile therapeutic strategy 187
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy 187
HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3. 187
Validity of body image perception in women with HIV. 184
Pathological fractures in patients with osteopenia and osteoporosis induced by antiretroviral therapy 183
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA 177
Studio caso-controllo sui fattori di rischio delle infezioni micotiche nei pazienti sottoposti a trapianto ortotopico di fegato (OLT) da donatore cadavere e da donatore vivente. 176
La casa alloggio: ospite, centro riabilitativo o entrambi? 176
Erectile dysfunction does not mirror sub-clinical atherosclerosis in HIV infected males. 173
Prevalence and risk factors of pubic lipomas in HIV-infected patients 172
Relapse of HIV-related buffalo hump after liposuction 172
Totale 26.712
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.251
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021598 0 0 0 0 0 0 0 0 0 280 195 123
2021/20222.286 31 374 189 246 53 85 118 177 220 134 367 292
2022/20232.854 300 261 229 240 316 467 46 288 333 55 166 153
2023/20241.739 111 139 122 176 283 151 149 199 52 60 104 193
2024/20255.789 219 94 93 387 1.230 791 461 287 658 258 619 692
2025/20269.015 674 477 893 1.237 1.715 756 1.000 489 985 789 0 0
Totale 32.251